Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. However, the two big drugmakers are also working together to develop a new blood thinner. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug.

Continue reading

Source Fool.com